Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valproic Acid for Chronic Lymphocytic Leukemia
NCT00524667Phase 2Terminated
- Sponsor
- CancerCare Manitoba
- Start
- Jan 2008
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of valproic acid in chronic lymphocytic leukemia (CLL), sponsored by CancerCare Manitoba. Started Jan 2008; status: terminated.
02
Drugs
valproic acid
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT00524667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00524667.